IBA expands its operations in Africa south of the Sahara and signs a contract with Sweden Ghana Medical Center for an IntegraLab® PLUS in Accra, Ghana
New contract to provide wider access to diagnostics in emerging markets
Louvain-La-Neuve, Belgium, 13 October 2022 – IBA (Ion Beam Applications SA, EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces a new contract with Sweden Ghana Medical Center (SGMC) for an IntegraLab® PLUS in Accra, Ghana. SGMC is a leading private cancer care center focused on providing the highest quality cancer care in West Africa. The contract marks IBA’s increasing presence in the region with operations in 21 countries.
IntegraLab® PLUS is a fully integrated solution that combines equipment and services to establish a radiopharmaceutical GMP production center, tailored to each customer’s specific needs. The contract includes delivery of an IntegraLab® solution, consisting of the installation and integration of a cyclone® KIUBE 100 with Synthera® Extension, Synthera®+ HPLC and IFP loader. Sweden Ghana Medical Center will benefit from IBA’s expertise for the full establishment of its radiopharmacy.
This contract follows several others signed in Tanzania and South Africa, and further highlights IBA’s ambition to widen access to cancer diagnostics and treatments in regions of the world with low population density and limited access to healthcare. Demand for diagnostic and therapeutic equipment in Africa is growing rapidly, with cancer cases rising to over 800,000 cases1 per year in sub-Saharan Africa.
This latest announcement follows IBA’s launch of the Cyclone® KEY in January this year, which will provide more widespread global access to diagnostic solutions in oncology, neurology and cardiology as it responds to a demand from the African market for a compact radiopharmaceutical production solution.
Olivier Legrain, Managing Director at IBA, commented: “This contract marks an important milestone for IBA as we expand the use of our technology into emerging markets such as Africa. Continued innovation from our RadioPharma Solutions business unit is critical to providing patients with access to much-needed diagnostics and treatments, something that is at the heart of IBA: s mission and is enhanced by the continued development of our technology. We look forward to working with SGMC and helping them achieve their mission to be at the forefront of cancer care in Africa.”
Dr. Clement Edusa, CEO and Medical Director at Sweden Ghana Medical Centre, added: “At SGMC, our vision is to provide the best possible cancer care across West Africa. IntegraLab® will allow us to provide the most innovative diagnostic imaging tests to our patients, with the hope that we can identify disease and therefore initiate appropriate treatment much more quickly. IBA’s technology gives us not only a cost-effective and user-friendly cyclotron system, but also customized solutions that meet our specific needs, allowing us to provide the best possible care to our patients.”
***ENDS***
About IBA
IBA (Ion Beam Applications SA) is a world leader in particle accelerator technology. The company is the leading provider of equipment and services in the field of proton therapy, considered the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company is based in Louvain-la-Neuve, Belgium, and has approximately 1,600 employees worldwide. IBA is a certified B Corporation (B Corp) that meets the highest verified social and environmental performance standards.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information is available at: www.iba-worldwide.com
About Sweden Ghana Medical Center (SGMC)
At SGMC, our vision is to offer the best private cancer care in West Africa. Our promise is that in everything we do, we will always strive to remove the burden of cancer.
Our mission is to be a role model across Africa for oncology care. SGMC’s medical team is known for its excellent standards and the high quality of services and personal care we provide. We are leaders in our field, with skilled employees who are motivated to deliver the best cancer treatment outcomes for all of our patients.
More information is available at: https://www.sgmccancercentre.com/
CONTACTS
IBA
Soumya Chandramouli
Finance manager
+32 10 475 890
[email protected]
Olivier Lechien
Communications Director
+32 10 475 890
[email protected]
Consilium strategic communication
Amber Fennell, Angela Gray, Lucy Featherstone
+44 (0) 20 3709 5700
[email protected]
1 https://gco.iarc.fr/today/data/factsheets/populations/971-sub-saharan-africa-hub-fact-sheets.pdf
Connection